Authors
Loading...
Benzimidazole-based copper(II) complexes enhance cytotoxicity in cancer cells, suggesting novel treatment options.
Saha et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: